Sine Reker Hadrup

Sine Reker Hadrup

Auto-generated profile, based on publicly available information

Sine Reker Hadrup

Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2016 in Science
Verified
Journal Article
Closed access
PDF file
NMNicholas McGranahan
Nicholas McGranahan
AFAndrew J. S. Furness
Andrew J. S. Furness
RRRachel Rosenthal
Rachel Rosenthal
SRSofie Ramskov
Sofie Ramskov
RLRikke Lyngaa
Rikke Lyngaa
CSCharles Swanton
Charles Swanton
The cellular ancestry of tumor antigens: One contributing factor in antitumor immunity is the repertoire of neoantigens created by genetic mutations within tumor cells. Like the corresponding mutations, these neoantigens show intratumoral heterogeneity. Some are present in all tumor cells (clonal), and others are present in only a fraction of cells (subclonal). In a study of lung cancer and melanoma, McGranahan et al. found that a high burden of clonal tumor neoantigens correlated with improved patient survival, an increased presence of tumor-infiltrating lymphocytes, and a durable response to immunotherapy. Science , this issue p. 1463

27 June 2016 in Nature
Verified
Journal Article
Closed access
EVEls M. E. Verdegaal
Els M. E. Verdegaal
Noel de MirandaNoel de Miranda
Noel de Miranda
MVMarten Visser
Marten Visser
THTom Harryvan
Tom Harryvan
MBMarit M. van Buuren
Marit M. van Buuren
SBSjoerd H. van der Burg
Sjoerd H. van der Burg

15 February 2006 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SHSine Reker Hadrup
Sine Reker Hadrup
JSJan Strindhall
Jan Strindhall
TKTania Køllgaard
Tania Køllgaard
TSTina Seremet
Tina Seremet
BJBoo Johansson
Boo Johansson
AWAnders Wikby
Anders Wikby
The age-associated decrease in functionality of the human immune system is thought to have a negative impact on the capacity to provide protection against infection, in turn leading to increased incidence of mortality. In a previous longitudinal study of octogenarians, we identified an immune risk phenotype (IRP) in the very elderly defined by an inverted CD4/CD8 ratio, which was associated with increased mortality and persistent CMV infection. In this study, we analyzed the CD8 clonal composition of nonagenarians and middle-aged individuals. An increased number of CD8 T cell clones was observed in the nonagenarians, and was associated with CMV-seropositivity. Surprisingly, CMV-seropositive nonagenarians with the IRP had a significantly lower number of clones compared with non-IRP individuals. The decrease in clone numbers in IRP individuals was associated with shorter survival time. MHC/peptide multimer staining indicated that the frequency of CMV-specific T cells was higher in nonagenarians than in the middle-aged, but the ratio of functionally intact cells was significantly lower. The lowest ratio of functional CMV-specific T cells was found in an IRP individual. A thorough longitudinal analysis of the CMV-specific T cells in nonagenarians showed a stable pattern with respect to frequency, phenotype, and clonal composition. We hypothesize that the number of different CD8 T cell clonal expansions increases as the individual ages, possibly, as a compensatory mechanism to control latent infections, e.g., CMV, but eventually a point is reached where clonal exhaustion leads to shrinkage of the CD8 clonal repertoire, associated with decreased survival.

29 August 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
ABAmalie Kai Bentzen
Amalie Kai Bentzen
AMAndrea Marion Marquard
Andrea Marion Marquard
RLRikke Lyngaa
Rikke Lyngaa
Sunil Kumar SainiSunil Kumar Saini
Sunil Kumar Saini
SRSofie Ramskov
Sofie Ramskov
SHSine Reker Hadrup
Sine Reker Hadrup

31 August 2006 in Nature Protocols
Verified
Journal Article
Closed access
BRBoris Rodenko
Boris Rodenko
MTMireille Toebes
Mireille Toebes
SHSine Reker Hadrup
Sine Reker Hadrup
WEWim J E van Esch
Wim J E van Esch
AMAnnemieke M Molenaar
Annemieke M Molenaar
HOHuib Ovaa
Huib Ovaa

16 December 2012 in Cancer Microenvironment
Verified
Journal Article
Open access
PDF file
SHSine Hadrup
Sine Hadrup
Marco DoniaMarco Donia
Marco Donia
PSPer thor Straten
Per thor Straten
T cells in tumors—the so-called tumor infiltrating lymphocytes (TIL) have been studied intensively over the past years. Compelling evidence point to a clinical relevance for high numbers of T cells at the tumor site with CD8 memory T cells as a key denominator for overall survival (OS) in patients with colo-rectal cancer (CRC), and also for others solid cancers. These data goes hand in hand with studies of clonality of TIL showing the T cells among TIL are expanded clonally, and also that tumor specific T cells of CD4 as well as CD8 type are enriched at the tumor site. The tumor microenvironment is hostile to T cell function e.g., due to expression of enzymes that depletes the amino acids tryptophan and arginine, high concentration of tumor secreted lactate, and presence innate cells or regulatory T cells both with suppressive activity. Analyses of the specificity of TILs in melanoma demonstrate that quite few known antigens are in fact recognized by these cultures underscoring patient unique and/or mutated antigens may represent important target for recognition.